Do contaminated foods commonly introduce aflatoxins, and does urinary aflatoxin M1 mark recent aflatoxin B1 exposure?

Aflatoxins are foodborne fungal toxins of major public-health importance; naturally occurring aflatoxins are Group 1 carcinogens. The claim is well supported: contaminated foods are the main exposure route, and urinary aflatoxin M1 (AFM1) is a short-term biomarker of aflatoxin B1 (AFB1) exposure and metabolism.

Exposure and biomonitoring

• Dietary ingestion is the principal human exposure pathway. Important sources include maize, groundnuts, rice, sorghum, wheat and other cereals, nuts, spices, legumes, cottonseed, and dried foods. The dominant sources vary with regional contamination and dietary patterns.
• AFM1 can also be present in milk and dairy products when livestock consume contaminated feed.
• Urinary AFM1 concentrations correlate with recent dietary AFB1 intake. Approximately 1–3% of ingested AFB1 is estimated to be recovered as urinary AFM1 over roughly 24–48 hours.
• Consequently, a detectable urinary AFM1 result supports recent AFB1 exposure and hepatic metabolism, not cumulative exposure, liver injury, or an individual cancer-risk estimate.

Mechanistic context

• In the liver, cytochrome P450 enzymes metabolize AFB1. CYP1A2 contributes to hydroxylation producing AFM1, which is excreted in urine.
• A separate metabolic pathway, with CYP3A4 a major contributor, forms reactive AFB1 8,9-epoxide. This metabolite can damage DNA and is central to AFB1 carcinogenicity.

Practical interpretation

• Spot-urine AFM1 results are influenced by recent meals, urine dilution, and sampling timing; a 24-hour urine collection is preferable when feasible.
• AFM1 cannot precisely reconstruct an individual’s AFB1 dose because metabolic conversion and urinary recovery differ among people. For longer-term exposure assessment, aflatoxin–albumin adducts provide complementary information.

Bottom line

• Contaminated food commonly introduces aflatoxins into the body, and urinary AFM1 is a well-established marker of AFB1 exposure and metabolism during the preceding 1–2 days—not a direct measure of chronic exposure or disease risk.